OTCMKTS:ABVEF

OTCMKTS:ABVEF - Above Food Ingredients Inc

AVOID [CAP] OPPORTUNISTIC BUY?AVOIDConsumer Defensive - Packaged FoodsAnalysis generated 2026-10-04Market data as of 2026-11-13Market data 2 days oldUSD 0.05

Conviction

out of 100

Executive Summary

Above Food Ingredients Inc is a Canada-based packaged food and ingredient company headquartered in Regina, Saskatchewan, that operates across the plant-based and specialty ingredients value chain, with reported activity spanning sourcing, processing and branded distribution. The company is positioned as a small-cap operator in the consumer defensive packaged foods segment, with a scale and listing profile that places it firmly in micro-cap territory and means liquidity and capital access matter as much as the underlying food business.

The investment case hinges on management's recently raised profit guidance and the progression of the previously announced strategic combination with Palm Global, both of which would need to land cleanly alongside a completed and clean audit. The key near-term catalyst is the publication of the delayed fiscal 2025 audited results, which remains the gating event before the FY 2026 profit guidance of more than USD40m can be treated as investable; the audit is the central risk because any further delay or qualification would undermine the credibility of the guidance raise and re-open the balance sheet and dilution questions.

AVOID. Conviction Score: 29/100. The view would shift to a stronger constructive stance on a clean, unqualified fiscal 2025 audit delivered within a defined window and visible progress on the Palm Global merger, and would shift to a defensive stance on any further audit delay, a going-concern flag, or evidence of a dilutive financing.

Bottom line - AVOID at 29/100. Not currently actionable.

Business Model

Above Food generates revenue across the packaged food and ingredients value chain, combining upstream ingredient processing with downstream branded and private-label distribution. The company has historically presented its operations as an integrated platform that takes specialty crops and pulses through ingredient processing and into finished food products for retail, food-service and ingredient customers, though the specific revenue split by segment is not confirmed in the available research and should be treated as unconfirmed.

Customer concentration, channel mix and gross margin profile are not disclosed in sufficient detail within the research data to support a granular revenue breakdown. What is clear from public commentary and the company press releases referenced in the research is that the business has been loss-making on a multi-year basis, with the FY 2026 profit guidance of more than USD40m and the prior expectation of more than USD30m for the year ended 31 January 2026 representing a sharp inflection rather than a continuation of the historical run-rate. The current price of USD0.04 and a 52-week high of USD0.13 indicate that the equity is being priced as a deep-value option on that inflection rather than as a going-concern earnings stream.

Any competitive moat at this stage is more narrative than demonstrated. Scale, brand equity and customer stickiness in packaged food and ingredients tend to accrue to larger incumbents, and Above Food's micro-cap profile, ongoing audit delay and historical losses mean the equity does not yet have the financial track record to anchor a structural moat. The Palm Global merger, if consummated, is presented as the catalyst that would scale the platform and reframe the competitive position, but the underlying ingredients business on a stand-alone basis has not yet delivered the operating proof required to underpin the current valuation.

Financial Snapshot

Price

USD 0.05

Market Cap

USD 2.2m

52w High

USD 0.13

Distance from 52wH

-61.5%

Beta

-0.23

Avg Volume

35886

Currency

USD

Recent Catalysts

[7 January 2026] - Above Food confirmed via a Newsfile Corp. press release that it expects to report more than USD30m in profit for the financial year ending 31 January 2026, marking a step-change versus the company's historical loss-making profile. Source: Newsfile Corp. company press release.

[17 February 2026] - Above Food announced, through Newsfile Corp., a major strategic milestone tied to the advancement of the merger with Palm Global, framed alongside the expected profit of more than USD30m for the fiscal year ended 31 January 2026. Source: Newsfile Corp. company press release.

[Late May 2026] - Above Food raised its FY 2026 profit outlook to more than USD40m, up from the prior USD30m-plus anchor, while disclosing that the fiscal 2025 audit remained delayed. Source: Stock Titan press release summary.

[PRNewswire release, undated within the research window] - Above Food issued a PRNewswire press release covering the Palm Global merger advancement and expected profit exceeding USD30m for the fiscal year ended 31 January 2026. Source: PRNewswire company press release.

[Unconfirmed timing] - Completion of the delayed fiscal 2025 audit and the related audited financial statements has not yet been published within the research window and is treated as the next material disclosure event. Source: Stock Titan / company disclosure.

Thesis Evaluation

Bull Case (20% weight)

The delayed fiscal 2025 audit lands cleanly and on a defined timetable, the FY 2026 profit guidance of more than USD40m is validated by audited results, and the Palm Global merger advances to a confirmed closing that materially expands scale and distribution. In that combination, micro-cap valuation re-rates from depressed option value towards a small-cap packaged food multiple, with a 12-month price target of USD0.10.

Base Case (48% weight)

The audit is eventually completed without a going-concern qualification but the timing remains uncertain, FY 2026 profit lands within a wide band of the USD40m-plus guidance, and the Palm Global merger progresses without a confirmed closing date. The stock continues to trade as a deep-value option on the inflection, with a 12-month price target of USD0.05.

Bear Case (32% weight)

Further audit delay, a going-concern qualification or a dilutive financing to bridge liquidity triggers a re-rating lower and a loss of NASDAQ compliance, with the Palm Global transaction either stalling or unwinding. In that scenario, the 12-month price target is USD0.01.

Weighted conviction:Bull (20%) x 100 + Base (48%) x 62 + Bear (32%) x 10 = 29/100. AVOID.

Key Risks

Audit delay and qualification risk: The fiscal 2025 audit remains outstanding and any further delay, qualification or going-concern flag would directly undermine the credibility of the raised FY 2026 profit guidance. Estimated probability: 40%. Impact: severe.
Balance sheet and liquidity risk: Issuer disclosures point to material balance sheet and liquidity pressure at a sub-USD50m market cap scale, with limited room to absorb operational setbacks or financing frictions. Estimated probability: 35%. Impact: severe.
Dilution and financing risk: A constrained cash position creates a credible path to a dilutive equity raise or instrument-based financing that would impair per-share value. Estimated probability: 30%. Impact: severe.
Listing and delisting risk: As a micro-cap name with an active audit delay, Above Food faces an elevated risk of non-compliance with continued listing standards on its primary venue. Estimated probability: 20%. Impact: severe.
Execution risk on the Palm Global merger: The strategic case rests materially on the Palm Global combination advancing to closing, and any failure or material renegotiation would weaken the platform-scaling narrative. Estimated probability: 25%. Impact: moderate.
Micro-cap liquidity and price volatility: With the stock at USD0.04 and a 52-week high of USD0.13, the equity exhibits the wide bid-ask swings and liquidity gaps typical of micro-cap names, which can amplify mark-to-market losses. Estimated probability: 60%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: High-risk-tolerant investors with a minimum 12 to 24 month holding horizon who are comfortable with micro-cap packaged food exposure, ongoing audit uncertainty and a thesis built around an operational inflection rather than current earnings power. Suitability requires capacity to absorb a potential 75% drawdown and tolerance for binary outcomes tied to audit delivery, merger progress and any dilutive financing.

Avoid if: Investors requiring audited financials, a current profitability track record, daily liquidity above micro-cap norms, or a defined catalyst path free of audit and listing risk. Conservative income-oriented mandates, large-cap-only mandates and investors unable to stomach the prospect of further dilution or a delisting event should not hold this name.

Recommendation

AVOID - 29/100. The tier reflects an asymmetric setup where a clean audit and visible merger progress can re-rate the equity sharply from a USD0.04 base, while the same setup carries severe downside if the audit slips further or liquidity forces a dilutive raise. The call would upgrade towards a higher-conviction constructive stance on publication of an unqualified fiscal 2025 audit, confirmed FY 2026 profit at or above the USD40m-plus anchor, and a definitive Palm Global closing timeline. The call would degrade towards a defensive stance on any further audit delay, a going-concern flag, evidence of a dilutive financing, or a NASDAQ compliance event. At the current price of $0.05 the shares trade at or above our base-case target of $0.05: the base case is fully priced, existing holders should consider trimming, and new positions are not advised above $0.02.

The probability-weighted value across our three scenarios is $0.05, 0% above the current price of $0.05 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $0.02 - below this level the upside to the base-case target ($0.05) is at least 2x the downside to the bear case ($0.01), the minimum risk/reward we require before committing new capital.

HOLD

between $0.02 and $0.05 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $0.05 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 20%.

SELL

if A going-concern qualification on the fiscal 2025 audit, a confirmed dilutive equity raise, or termination of the Palm Global merger, regardless of price - the bear target of $0.01 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 29/100. Trend versus prior report: Flat.

CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)

Report date	Conviction
2026-11-14	29
2026-10-04	29

See the trade-card view →

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow drawn from company press releases distributed via Newsfile Corp. and PRNewswire, regulatory and disclosure-oriented financial news wires including Stock Titan, and aggregator coverage on Yahoo Finance, Stock Analysis, MarketBeat and Insider Monkey used only for background colour.

Primary source types: Company press releases, regulatory and listing disclosures, third-party financial news wire coverage, and aggregator commentary used for cross-reference rather than as the basis for any factual claim.

Key sources

Analysis generated 2026-10-04. Market data as of 2026-11-13.